Today Norton's "dose-dense" regimen is common practice for certain breast cancer patients at high risk of relapse after surgery.

FORBES: Magazine Article

"You cannot give dose-dense chemotherapy without Neupogen, " says Marc Citron, a professor at Albert Einstein College of Medicine in Brookeville, N.

FORBES: Magazine Article